Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001959173-25-005742
Filing Date
2025-09-03
Accepted
2025-09-03 13:50:59
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2926
  Complete submission text file 0001959173-25-005742.txt   4618
Mailing Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140
Business Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140 617-655-6580
Vor Biopharma Inc. (Subject) CIK: 0001817229 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39979 | Film No.: 251288720
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 101 MISSION STREET, SUITE 1000 SAN FRANCISCO CA 94105
Business Address 101 MISSION STREET, SUITE 1000 SAN FRANCISCO CA 94105 415-541-0200
Reprogrammed Interchange LLC (Reporting) CIK: 0002050755 (see all company filings)

EIN.: 364889533 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 144